Blog

J D Wetherspoon (LSE:JDW) has reported a 5.1% increase in like-for-like sales over the past 12 weeks and year-to-date, driven by a strong recovery in sales volumes following the pandemic. The company experienced notable growth in wine, spirits, and draught volumes, alongside a significant rise in food sales—especially breakfasts and chicken dishes—which have surpassed pre-pandemic levels. Looking ahead, J D Wetherspoon plans to open 15 new managed pubs and an equal number of franchised pubs in the next financial year.

The company’s stock is on a recovery trajectory, supported by improving financial performance and solid technical indicators. Strategic share buybacks and director share purchases signal management’s confidence in the company’s growth prospects. However, elevated leverage and moderate profitability remain potential risks.

More about J D Wetherspoon

J D Wetherspoon operates a network of pubs across the UK and Ireland, offering quality food and beverages at competitive prices. The company prides itself on well-trained staff and uniquely designed pubs that are meticulously maintained.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Shield Therapeutics (LSE:STX) reported a substantial increase in Q2 2025 net revenues for its ACCRUFeR® product, which doubled from Q1 to $12.8 million. This growth was driven by higher prescription volumes and an improved average net selling price. The company’s cash position was strengthened through milestone payments from international partners, supporting its goal of achieving positive cash flow by the end of 2025. The strong uptake of ACCRUFeR® highlights its potential to become the leading oral iron therapy for patients with iron deficiency, enhancing Shield’s strategic market presence.

Despite robust revenue growth and favorable corporate developments, Shield Therapeutics faces financial challenges. Technical indicators show upward momentum but suggest possible volatility ahead, while valuation metrics remain a concern.

More about Shield Therapeutics

Shield Therapeutics plc is a specialty pharmaceutical company at the commercial stage, focused on treating iron deficiency with its innovative ACCRUFeR®/FeRACCRU® (ferric maltol). This therapy is the first and only FDA-approved oral iron treatment for iron deficiency and anemia, featuring a unique absorption mechanism. Shield holds exclusive licensing agreements for ACCRUFeR® across key global markets including the U.S., Europe, China, and Japan.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Hochschild Mining (LSE:HOC) delivered solid operational results in Q2 2025, driven by strong production at its Inmaculada and San Jose mines. However, the company faced challenges at its Mara Rosa operation in Brazil, leading to a temporary suspension of the plant for process improvements and maintenance. Hochschild plans to provide a detailed update on Mara Rosa at its interim results scheduled for late August. Financially, the company reported increased cash reserves, lower net debt, and reaffirmed its commitment to ESG principles by joining the United Nations Global Compact.

The outlook for Hochschild Mining is positive, supported by robust revenue growth, operational efficiency gains, debt reduction, and dividend reinstatement. While earnings volatility and operational risks persist, the company’s valuation remains reasonable, reflecting confidence in its long-term strategy.

More about Hochschild Mining

Hochschild Mining PLC is a precious metals miner specializing in gold and silver extraction. It operates key sites including the Inmaculada and San Jose mines and is advancing exploration and development projects such as Monte Do Carmo.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Fresnillo PLC (LSE:FRES) posted strong silver and gold production results for Q2 2025, with gold output nearing the higher end of the full-year forecast. Although some mines experienced lower ore grades and mining activities at San Julián DOB were halted, gold production still rose by 1.0% quarter-on-quarter. Silver production, however, dropped 14.7% compared to the same period last year. The company also faced the tragic loss of two employees, leading to renewed emphasis on safety protocols.

Looking ahead, Fresnillo maintains its 2025 production guidance for both silver and gold. The company’s robust financial position and healthy cash flow are bolstered by strong cost controls and strategic efforts. Technical indicators point to sustained momentum, although valuation concerns could temper further gains. Insights from recent earnings calls underline stable production and a focus on delivering shareholder value.

More about Fresnillo

Fresnillo PLC is a prominent precious metals miner with a primary focus on silver and gold extraction. Operating multiple mines across Mexico, the company prioritizes operational efficiency and cost management to drive production growth.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

CyanConnode Holdings (LSE:CYAN) reported a 24% revenue decline for the fiscal year ending March 2025, largely due to election-related uncertainty and consumer hesitation in India, its largest market. Nevertheless, the company’s order book surged to £180 million—tripling year-on-year—with a landmark £70 million contract awarded by the Government of Goa, highlighting strong demand for its technology solutions.

To improve transparency, CyanConnode will start providing quarterly updates and has taken a cautious stance on future forecasts. Financially, the firm reduced its operating losses and improved gross margins thanks to cost-efficient product launches. Expansion efforts included establishing a UAE subsidiary and winning smart metering contracts in India, reinforcing its regional footprint.

While CyanConnode shows promise through significant order growth and strategic expansions, ongoing profitability challenges and cash flow issues remain concerns. Technical signals point to a potential recovery, but valuation pressures persist due to the company’s continued losses.

More about CyanConnode Holdings

CyanConnode Holdings plc is a specialist provider of narrowband RF smart mesh network technology, serving smart metering and IoT markets globally. With a strong focus on India, the company has also broadened its reach into the Middle East and North Africa regions.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

FRP Advisory Group Plc (LSE:FRP) has delivered strong full-year results for the period ending April 30, 2025, with revenue climbing 19% to £152.2 million and adjusted underlying EBITDA increasing by 11% to £41.3 million. Growth was driven by strong contributions across all service lines and successful acquisitions. Despite ongoing economic uncertainties, the company expanded its workforce by 21% and maintained a healthy balance sheet, ending the year with net cash of £33.3 million. Trading in the new financial year is in line with the Board’s expectations, positioning FRP well to capitalize on emerging market demands.

The outlook for FRP Advisory Group remains positive, supported by robust financial results and strategic corporate developments. While valuation appears fair and attractive to investors, some caution is warranted based on technical indicators. Overall, the company’s financial strength and strategic initiatives provide a solid foundation for continued growth.

About FRP Advisory Group Plc

Founded in 2010, FRP Advisory Group Plc is a leading national specialist business advisory firm offering a comprehensive range of services. These include restructuring, corporate finance, debt advisory, forensic investigations, and financial advisory to businesses, lenders, investors, and individuals.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Guardian Metal Resources Plc (LSE:GMET) has successfully raised approximately £15.6 million (equivalent to US$21.0 million) through an equity fundraising round led by its largest shareholder, UCAM Limited. The capital will be directed towards advancing critical activities at its Pilot Mountain and Tempiute tungsten projects, including drilling programs, engineering assessments, and permitting processes. The company aims to complete a comprehensive pre-feasibility study by the first half of 2026.

In addition to this funding, Guardian Metal Resources recently received a US$6.2 million award under the DPA Title III program, further supporting its efforts to develop a reliable domestic supply of tungsten for the United States.

About Guardian Metal Resources Plc

Guardian Metal Resources Plc focuses on the exploration and development of tungsten assets in Nevada, USA. The company’s flagship projects, Pilot Mountain and Tempiute, are strategically positioned to help restore U.S. domestic tungsten production, with particular emphasis on meeting defense industry needs.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Itaconix plc (LSE:ITX) announced record first-half revenues of $4.8 million for 2025, representing a 73% year-over-year increase. This strong performance was largely driven by growth in the cleaning products segment and the successful introduction of new offerings such as the BIO*Asterix® range. Additionally, the company deepened its partnership with Croda Inc., strengthening its foothold in the odor control market.

Despite robust top-line growth and a solid equity position, Itaconix experienced a decline in net cash, mainly due to increased inventory investments. The company continues to face challenges related to profitability and cash flow. Technical indicators point to bearish trends, and valuation remains subdued. Nevertheless, ongoing product innovation and strategic partnerships provide a cautiously optimistic outlook for future expansion.

About Itaconix

Itaconix plc specializes in developing sustainable, plant-based polymers that improve the safety, effectiveness, and environmental impact of consumer and industrial products. Leveraging proprietary itaconic acid technology, the company offers high-performance materials across a variety of applications.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Manx Financial Group PLC (LSE:MFX) has announced that its subsidiary, Payment Assist Limited (PAL), has secured five significant new lending partnerships, expected to increase annual loan advances by £27 million and boost revenues by more than £5 million. These agreements involve collaborations with key players such as the Retail Automotive Alliance, eDynamix, Car Care Plan, Nissan Motor GB, Fix Auto UK, and Revive! Auto Innovations, enhancing PAL’s Buy Now Pay Later (BNPL) offerings across a range of automotive services.

This strategic move is set to reinforce Manx Financial’s foothold in the UK automotive finance market, opening up promising avenues for growth.

While the company benefits from solid financial results and an appealing valuation, short-term technical signals show a mixed picture. Continued record profit growth and a clear focus on supporting SMEs contribute to a favorable outlook, although moderate leverage will need ongoing attention.

About Manx Financial Group

Manx Financial Group PLC is a diversified financial services holding company based in the Isle of Man and the UK. Through its fully owned subsidiary, Payment Assist Limited, the group specializes in providing BNPL finance solutions, with a particular emphasis on the automotive sector.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.